Exploring Lipid Metabolic Reprogramming: Mechanistic Insights and Implications for Tumor Radiotherapy

Area of Science:

• Oncology
• Metabolic pathways
• Radiotherapy

Background:

• Lipid metabolic reprogramming is integral to tumor progression and therapy response.
• Specific lipid pathways like ferroptosis, cholesterol remodeling, and lipid droplet metabolism critically influence radiosensitivity.
• Tumor-microenvironment interactions mediated by lipids are key determinants of radioresistance.

Purpose of the Study:

• To review the multifaceted roles of lipid metabolism in modulating tumor response to ionizing radiation (IR).
• To differentiate inherent tumor lipid profiles from adaptive responses to IR.
• To explore therapeutic strategies targeting lipid vulnerabilities for improved radiotherapy outcomes.

Main Methods:

• Literature review and synthesis of current research on lipid metabolism and radiotherapy.
• Analysis of lipid pathways involved in oxidative damage, membrane integrity, ferroptosis, and immune regulation.
• Evaluation of intercellular lipid communication and its role in radioresistance.

Main Results:

• Lipid metabolic reprogramming influences radiosensitivity through pathways including lipid peroxidation, ferroptosis, membrane integrity, and energy metabolism.
• Tumor lineage, genetics, microenvironment, and treatment context dictate the impact of lipid programs on radiosensitivity.
• Intercellular lipid transfer, nutrient competition, and lipid mediators are crucial for radioresistance.

Conclusions:

• Understanding tumor lipid programs and adaptive responses is essential for predicting radiotherapy outcomes.
• Exploiting lipid vulnerabilities presents promising therapeutic opportunities to enhance radiation therapy.
• Targeting lipid metabolism offers a translational approach to improve cancer treatment efficacy.